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percentage of VM patients during the course of the disease. 
The presence of COMD is predictive of VM in patients with 
recurrent attacks of vertigo. Prophylactic migraine medica-
tion seems to attenuate the development and progression 
of COMD.  Copyright © 2012 S. Karger AG, Basel 
 Introduction 
 During the last decade, vestibular migraine (VM) has 
been acknowledged to be a relevant clinical entity not 
only in dizziness units. With a lifetime prevalence of 1%, 
VM is the most common cause of episodic vertigo  [1] . Re-
current attacks of moderate to severe vertigo are strongly 
associated with migraine-like headache and/or migrain-
ous symptoms such as phonophobia, photophobia, or 
aura. In 2001, Neuhauser et al. [2] proposed criteria for 
establishing a diagnosis of VM on the basis of the pa-
tients’ presenting symptoms and medical history. How-
ever, because clinical presentation is unspecific, an accu-
rate diagnosis is often made only late in the course of the 
disease  [3, 4] . A clinical test that reliably predicts VM in 
an early stage would be helpful. 
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 Abstract 
 Background: A high percentage of patients with vestibular 
migraine (VM) were reported to have central ocular motor 
dysfunctions (COMD) in the symptom-free interval. Since VM 
is a chronic disorder, it is of interest if COMD worsen over 
time.  Methods: Thirty VM patients and 11 control patients 
participated in an 8-year-long observational study with fol-
low-up. All patients underwent standardized neuro-oph-
thalmological and neuro-otological examinations at the ini-
tial presentation and at follow-up. The primary outcome 
measure was change in COMD at follow-up.  Results: In gen-
eral, COMD in the symptom-free interval were subtle, con-
sisting of a saccadic horizontal and/or vertical pursuit. At fol-
low-up, significantly more patients with VM had COMD (p = 
0.015). The prevalence of COMD increased from 20 to 63% in 
VM patients. Further, the presence of COMD at follow-up had 
a positive predictive value of 90.5% for the diagnosis of VM. 
Successful treatment with prophylactic migraine medica-
tion seems to prevent the development and worsening of 
COMD (p = 0.008). Conclusion: Mild COMD occur in a large 
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 A large percentage of patients with VM have been re-
ported to have central ocular motor dysfunctions (COMD; 
18.8–65%) such as saccadic pursuit, spontaneous or gaze-
evoked nystagmus, and positional nystagmus  [5–7] . The 
high incidence (65%) found by Dieterich and Brandt [5] 
is in line with prior studies that examined migrainous 
patients with vertigo. Kayan and Hood  [6] described per-
sisting ocular motor derangements in 77.5% of their
patients, which were either central (18.8%), peripheral 
(28.8%), or inconclusive (30%) in origin. Bir et al. [7] 
found electronystagmography (ENG) abnormalities in 
58% of patients with migraine and vertigo. In contrast, 
current studies that included patients with migraine and 
vertigo according to the Neuhauser criteria showed dif-
ferent results. One study reported central ocular motor 
disturbances in 16.6%, while two other studies reported 
central ocular motor signs in only about 8% of patients 
with VM  [8–10] .
 Since VM is a chronic disorder with recurrent attacks 
of vertigo, the question arises as to whether the reported 
COMD worsen over time. From a diagnostic and patho-
physiologic point of view it would be interesting to deter-
mine both the presence and the development of COMD 
over the course of the disease. We therefore performed a 
long-term study on 30 patients with VM who underwent 
a standardized examination of ocular motor functions at 
the time of diagnosis and at follow-up. Control patients 
were those who presented to our dizziness unit in the 
same time frame and had had an initial diagnosis of VM, 
but a re-diagnosis during follow-up of vestibular disor-
ders other than VM. 
 Patients and Methods 
 Patients 
 Patients diagnosed to have VM in the period from 1997 to 2001 
were identified in the database of our dizziness unit. Thirty pa-
tients presented for a follow-up examination and were included in 
the study. The original diagnoses of VM were revised according 
to the criteria of Neuhauser et al.  [2] to ‘definite VM’ and ‘prob-
able VM’. Eleven age- and sex-matched patients were included in 
the control group. These patients had presented to our dizziness 
unit in the same period with similar symptoms and an initial di-
agnosis of VM but at follow-up the diagnosis had been revised 
( table 1 ). Except for ocular motor dysfunctions, all patients had a 
normal neurological status. Routinely done brain imaging in all 
patients did not reveal any causative lesions. The control group 
was chosen to determine the appropriate diagnosis for episodic 
vertigo. We did not choose patients with central vestibular disor-
ders other than VM, because they usually present with different 
ocular motor disturbances and are most often diagnosed by the 
presence of additional neurological signs and abnormal brain im-
aging.
 The diagnosis of migraine was made according to the IHCD-2 
(International Headache Society Classification Subcommittee; 
2004)  [11] during a face-to-face interview and on the basis of a 
short questionnaire. Vertigo was not considered an aura symptom 
for the diagnosis of migraine with aura. 
 A standardized history was taken from all patients including 
characteristics of vertigo like frequency, duration, intensity and 
postural imbalance during the attack, associated migrainous 
symptoms (headache, photophobia, phonophobia, visual and 
other auras), a past medical history of migraine according to the 
International Headache Society and a family history of migraine 
headache. The treatment response to prophylactic migraine med-
ication was also evaluated. A positive response was defined as a 
more than 50% reduction of vertigo frequency or intensity from 
baseline. Patients were asked to estimate the effect of reduction in 
percent on an analog scale. 
 Methods 
 All patients underwent identical, standardized, complete 
neurological, neuro-ophthalmological and neuro-otological ex-
aminations when presenting and at follow-up. They included ex-
amination for spontaneous nystagmus with Frenzel’s goggles, 
gaze-evoked nystagmus, smooth pursuit, saccades, optokinetic 
nystagmus, visual fixation suppression of the vestibulo-ocular 
reflex (VOR), rebound nystagmus, head-shaking nystagmus, 
and the Halmagyi-Curthoys head-impulse test. The subjective 
visual vertical as well as eye position in the roll plane were also 
determined with a scanning laser ophthalmoscope. The results 
of the follow-up were compared with records from the initial 
presentation.
Table 1. D istribution of age and sex between the study groups (mean 8 SD)
 dVM  pVM  dVM+pVM No VM
Total 18 12 30 11
Age, years 53812.7 61.288.7 56.2811.9 63.1810.0
Mean follow-up, years 7.981.4 8.181.7 8.081.5 8.081.5
Females/males 14/4 4/8 18/12 8/3
dVM = Definite VM; pVM = probable VM; dVM+pVM = VM; No VM = control group.
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 ENG and bithermal caloric irrigation were performed in all 
patients who were examined by ENG at initial presentation, and 
the mean peak slow-phase velocity (MSPV) was determined. Ves-
tibular paresis was defined as either an asymmetry of more than 
25% between the right-sided and left-sided response or a unilat-
eral response with a MSPV (30° + 44°) of less than 10°/s. 
 Statistical Analysis 
 Statistical analyses included frequency and descriptive statis-
tics. All calculations were performed using the R software pack-
age, version 2.11.1 (www.r-project.org). Fisher’s exact test was ap-
plied to compare proportions. Nonparametric procedures were 
used to assess differences in quantitative measurements. Results 
are given as mean  8 SD. For statistical analysis, patients with 
definite VM and those with probable VM were pooled (VM 
group) and compared with the control group, i.e. patients without 
VM.
 Results 
 Eighteen patients fulfilled the diagnostic criteria for 
definite VM and 12 for probable VM. Vertigo in the con-
trol group was due to Meniere’s disease in 2, benign par-
oxysmal positional vertigo in 3, unilateral peripheral ves-
tibular deficit most likely due to vestibular neuritis in 2, 
phobic postural vertigo in 2, bilateral vestibulopathy in 1 
and orthostatic hypotension in 1.
 Patients with definite VM were 53  8 12.7 years old, 
patients with probable VM 61.2  8 8.7 years old, and pa-
tients in the control group 63.1  8 10.0 years old (mean 
 8 SD). Despite the slightly younger age of patients with 
definite VM, there was no statistically significant differ-
ence in age among the three groups (p = 0.076, Kruskal-
Wallis test). Likewise, the small difference in sex was also 
not significant (0.716, Fisher’s exact test). The follow-up 
time was 7.9  8 1.4 years for patients with definite VM, 
8.1  8 1.7 years for patients with probable VM, and 8.0  8 
1.5 years (mean  8 SD) for the control group.
 Findings in the neuro-ophthalmologic examination 
(see  table 2 ) were classified as central ocular motor dis-
turbances by our team of orthoptists, who had examined 
the patients over the years in a standardized fashion. Cen-
tral ocular motor disturbances were documented if ocu-
lar motor abnormalities were clearly central in origin, e.g. 
a disturbance of smooth pursuit. Unspecific signs such as 
isolated unilateral gaze-evoked nystagmus and dissoci-
ated gaze-evoked nystagmus or isolated deviations of the 
subjective visual vertical without further central ocular 
motor signs were classified as normal.
 In general, central ocular motor signs were subtle, 
consisting of a saccadic horizontal and/or vertical pur-
suit. Unspecific central ocular motor signs were infre-
quent and mainly seen in the control group. Central ocu-
lar motor signs were detected at initial presentation in 6 
patients with VM (definite and probable) and in 1 patient 
of the control group (p = 0.65, Fisher’s exact test). Nine-
teen patients with VM presented with central ocular mo-
tor signs at follow-up compared to 2 patients of the con-
trol group (p = 0.015, Fisher’s exact test). Thus, the central 
Table 2. C entral ocular motor signs in the symptom-free interval in patients with dVM and pVM versus no VM 
patients at initial presentation and follow-up
Initial presentation F ollow-up
dVM pVM no VM dVM pVM no VM
Normal
Strabismus
Central ocular motor disturbancea
Saccadic vertical pursuit
Saccadic horizontal pursuit
Cancellation of VOR
Unilateral gaze-evoked nystagmus
Dissociated gaze-evoked nystagmus
Spontaneous nystagmus (>5°/s)b
Deviation of the subjective visual vertical (>82.5°)c
13
0
5
5
3
0
0
1
1
0
11
2
1
1
1
0
0
1
0
0
10
0
1
0
1
0
4
1
0
1
4
0
14
12
8
1
1
0
0
1
7
2
5
5
4
0
2
0
1
0
8
0
2
1
2
1
1
2
0
2
dVM = Definite VM; pVM = probable VM; no VM = control group.
a M ultiple answers possible. b In combination with other central ocular motor signs and/or a directional 
preponderance in caloric testing. c In combination with other central ocular motor signs.
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ocular motor signs worsened over the years in 13 patients 
with VM and in 1 patient of the control group (p = 0.064, 
Fisher’s exact test). Expressed in terms of test perfor-
mance parameters, the development of central ocular 
motor signs had a positive predictive value (PPV) of 
92.86% (95% CI 68.53–98.73) for the diagnosis of VM. 
The presence of central ocular motor signs at follow-up 
showed a PPV for the diagnosis of VM of 90.48% (95% CI 
71.09–97.35).
 Twenty-one patients with VM reported having a posi-
tive past medical history of migraine headache (11 with 
and 10 without aura) in contrast to only 2 patients in the 
control group (1 with and 1 without aura; p = 0.005, Fish-
er’s exact test). Twenty-six patients with VM experienced 
migrainous symptoms during attacks of vertigo com-
pared to only 5 patients in the control group (p = 0.013, 
Fisher’s exact test). Patients suffering from VM showed 
significantly more migrainous symptoms than patients 
of the control group (p = 0.017, Cochrane-Armitage trend 
test).
 Four patients in the control group perceived the inten-
sity of vertigo as low, whereas none of the VM patients 
experienced only a low intensity of vertigo. Five patients 
of the control group reported a moderate intensity com-
pared to 15 patients with VM. Only 2 control patients 
reported severe vertigo in contrast to 15 patients in the 
VM group (p = 0.004, Fisher’s exact test).
 Eighteen patients with VM reported a positive re-
sponse to prophylactic migraine medication, whereas 7 
did not improve and 4 did not take the prescribed medi-
cation. Fifteen patients took beta-blockers as prophylac-
tics, 2 sodium valproate, and 1 patient flunarizine. Five 
of the 11 patients in the control group were also treat-
ed with prophylactic migraine medication early in the 
course of their disease: 4 received beta-blockers and 1 so-
dium valproate. As expected, none of them improved 
over time. A comparison of both groups showed a sig-
nificant difference in the response to prophylactic mi-
graine medication in favor of the patients with VM (p = 
0.001, Fisher’s exact test). Clinical characteristics and sta-
tistical analysis are summarized in  table 3 . 
 In view of the influence of prophylactic migraine med-
ication on the development of central ocular motor dis-
turbances in patients with VM, patients with a positive 
response to migraine medication were compared with 
patients who did not benefit from prophylactic treatment. 
Fourteen of 18 patients (77.8%) who responded to treat-
ment showed stable ocular motor characteristics com-
pared to 3 of 12 patients (25%) who did not respond. The 
remaining 4 patients (22.2%) and 9 patients (75%), re-
spectively, developed additional ocular motor distur-
bances. This difference was statistically significant (p = 
0.008, Fisher’s exact test).
 ENG testing was performed in 24 patients at initial 
presentation and in 18 patients at follow-up in the VM 
 group. None of the patients had a canal paresis at initial 
presentation. At follow-up, 6 patients showed an asym-
metry of more than 25% between the right-sided and the 
left-sided response. However, 4 patients showed a normal 
response to either warm-water or cold-water irrigation. 
Thus, a definite canal paresis was found in only 2 pa-
tients. Seven patients in the control group underwent 
ENG testing at initial presentation and 5 at follow-up. A 
definite canal paresis was not documented at initial pre-
sentation, but was found in 2 patients at follow-up. A 
Table 3. C linical characteristics of patients with VM (definite and 
probable migrainous vertigo) versus no VM
Clinical features No VM VM p value (Fisher’s 
exact test)
COMS initial presentation
Yes
No
1
10
6
24
0.651
COMS follow-up
Yes
No
2
9
19
11
0.015
Change in COMS
Yes
No
1
10
13
17
0.064
Migraine according to the IHS
Yes
No
2
9
21
9
0.005
Family history of migraine
Yes
No
2
9
21
9
0.005
Migrainous symptoms during vertigo
Yes
No
5
6
26
4
0.013
Intensity of vertigo
Low
Moderate
Severe
4
5
2
0
15
15
0.004
Gait disturbance
Yes
No
6
5
20
10
0.491
Response to prophylactic migraine medication
Yes
No
0
7
18
7
0.001
COM S = Central ocular motor signs; IHS = International 
Headache Society.
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comparison of both groups showed no statistical differ-
ence either at initial presentation (p = 0.492, Fisher’s ex-
act test) or at follow-up (p = 0.156, Fisher’s exact test). 
Patients who had a complete ENG workup including 
smooth pursuit testing at initial presentation and at fol-
low-up showed identical central ocular motor distur-
bances as they did in the neuro-ophthalmologic exami-
nation.
 Discussion 
 This study showed that the prevalence of central ocu-
lar motor signs in the symptom-free interval of patients 
with VM increases during the course of the disease. How-
ever, these disturbances were only mild, and if initially 
present, did not significantly worsen over the years. In 
general, central ocular motor signs were subtle, consist-
ing of a saccadic horizontal and/or vertical pursuit. Un-
specific signs, such as spontaneous or unilateral gaze-
evoked nystagmus, were infrequent and mainly seen in 
the control group. 
 The different prevalences of central ocular motor 
findings are in line with previous reports. The high prev-
alence at follow-up agrees with previous findings  [5] , 
whereas the low prevalence at initial presentation is com-
parable to the results of recent studies that reported 
around 8 and 16.6%  [8–10] . Thus, the clear-cut increase 
in central ocular motor findings at follow-up explains 
well the different results reported in earlier studies as be-
ing due to a time bias. A population bias, on the other 
hand, is unlikely, because the inclusion criteria were iden-
tical  [2] . Furthermore, the comparable distribution of 
findings in our study and in other studies is indirect 
proof that the populations of patients were similar (e.g. 
percentage of peripheral vestibular deficit in our study 11 
vs. 8.3–28.8% in previous studies)  [5, 6, 8, 9, 12] .
 Despite the diagnostic criteria published by Neuhau-
ser et al.  [2] , which have been proven valid and reliable 
 [13] , the diagnosis of VM can still be difficult. It is current 
practice to exclude relevant differential diagnoses in pa-
tients with suspected VM, to observe their response to 
migraine medication, and to follow up the patients. Mild 
central ocular motor disturbances are thought to point to 
a diagnosis of VM  [5] . The data of this study show that 
central ocular motor signs at initial presentation do not 
occur more frequently in patients with VM than in pa-
tients with vertigo due to a disease other than VM, but 
they do occur at follow-up in significantly more patients 
with VM. Therefore, central ocular motor signs are of 
small diagnostic value initially, but their presence at fol-
low-up reliably indicates VM. Similarly, the development 
of central ocular motor signs over the years is predictive 
of VM in the majority of cases. It is tempting to speculate 
that central ocular motor signs could also be of equal di-
agnostic value in patients who present for the first time 
after having suffered from recurrent attacks of vertigo for 
years. 
 Despite their increased prevalence, central ocular mo-
tor signs did not worsen during the follow-up interval in 
patients who initially presented with central ocular mo-
tor signs. The data do not clearly show if this observation 
reflects the natural course of the disease. We suspect that 
the stable characteristics of central ocular motor distur-
bances are due to the treatment effects of prophylactic 
migraine medication. Possible causes of VM are vaso-
spasms within the vestibular and/or auditory labyrinth 
 [14–16] and dysfunction of voltage-sensitive ion channels 
or neurotransmitters alone or in combination with 
spreading depression  [5, 17–22] . Just as the pathophysio-
logical mechanisms underlying VM have not yet been 
unraveled, it is also unclear how migraine prophylactics 
influence the course of the disease. However, patients 
who were successfully treated with prophylactics in our 
study experienced a reduction in attack frequency, dura-
tion and intensity, and were more likely to show stable 
ocular motor characteristics, whereas patients who failed 
to respond to treatment, for whatever reasons, were more 
likely to develop ocular motor signs at follow-up. It is im-
portant to note that the small size of the study and the 
retrospective acquisition of treatment parameters such as 
dose, duration and adherence limit our ability to infer 
treatment effects.
 We have to emphasize that uncritical standard inter-
pretation of mild ocular motor signs – essentially mild 
smooth pursuit disorder – might be problematic. Because 
smooth pursuit much depends on attention, good coop-
eration of the patient is a critical precondition. Otherwise 
smooth pursuit is even saccadic in normal subjects. Some 
authors suggest testing for cancellation of the VOR dur-
ing combined eye-head tracking to infer on smooth pur-
suit if a direct examination is difficult to achieve. As a 
general rule, lesions disrupting smooth pursuit impair 
VOR cancellation in the same way  [23] . In contrast, de-
generative diseases of the brainstem and cerebellum show 
a discrepancy between the poor performance of smooth 
pursuit and a superior performance of VOR cancellation 
 [24] . Therefore, the well-preserved function of VOR can-
cellation and the poor smooth pursuit observed in our 
cohort do not suggest poor cooperation, but do point to-
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wards central infratentorial dysfunction of the ocular 
motor system.
 In conclusion, our findings indicate that although cen-
tral ocular motor signs are only mild and stable, they may 
be of diagnostic value for VM for the critical clinician. 
Patients with recurrent attacks of vertigo readily exhibit 
an interruption of smooth pursuit but preserved VOR 
cancelation during the ocular motor examination; this 
makes a diagnosis of VM most likely. In contrast, ocular 
motor findings other than interrupted saccadic pursuit at 
both the initial presentation and at follow-up point to a 
different diagnosis.
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